
GC63322
MMP13-IN-3
Also known as 4-[[[5-(2-ethoxycarbonyl-1H-indol-5-yl)-1-methylpyrazole-3-carbonyl]amino]methyl]benzoic acid
MMP13-IN-3 is a potent, selective, and orally active MMP-13 inhibitor (IC50=1 nM) for the potential treatment of osteoarthritis
ChemicalCAS1222173-37-6MW446.46FormulaC24H22N4O5
- CAS number
- 1222173-37-6
- Molecular weight
- 446.46
- Formula
- C24H22N4O5
- Solubility
- DMSO : 100 mg/mL (223·98 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- MMJPVSDTLGFIQW-UHFFFAOYSA-N
- Catalogue number
- GC63322
- Brand
- GLPBIO
Computed properties PubChem CID 45376872 · XLogP 3.2 · TPSA 126 Ų · H-bond donors 3
- XLogP
- 3.2
- TPSA
- 126 Ų
- H-bond donors
- 3
- H-bond acceptors
- 6
- Rotatable bonds
- 8
- Heavy atoms
- 33
SMILES CCOC(=O)C1=CC2=C(N1)C=CC(=C2)C3=CC(=NN3C)C(=O)NCC4=CC=C(C=C4)C(=O)O
Computed descriptors from PubChem (CID 45376872), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il